Skip to main content
. 2022 Nov 25;35:100856. doi: 10.1016/j.neo.2022.100856

Fig. 5.

Fig 5

CX-5461 may be a moderator of immunotherapy to suppress tumor growth in vivo. a Flow of the CT26 animal model treatment with CX-5461, anti-PD-L1, or their combination (n = 4 in each group). b–d Representative bar graph of tumor size b, photographs c, and body weight d of mice in the vehicle, anti-PD-L1, CX-5461, and anti-PD-L1+CX-5461 groups. e Kaplan–Meier plot of survival rates after different drug treatments. Data were analyzed using paired t test.